299 related articles for article (PubMed ID: 16676578)
1. [Aromatase--key enzyme of estrogen biosynthesis].
Milczarek R; Klimek J
Postepy Biochem; 2005; 51(4):430-9. PubMed ID: 16676578
[TBL] [Abstract][Full Text] [Related]
2. Organization of the human aromatase p450 (CYP19) gene.
Bulun SE; Takayama K; Suzuki T; Sasano H; Yilmaz B; Sebastian S
Semin Reprod Med; 2004 Feb; 22(1):5-9. PubMed ID: 15083376
[TBL] [Abstract][Full Text] [Related]
3. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
[TBL] [Abstract][Full Text] [Related]
4. Regulation of breast cancer-associated aromatase promoters.
Chen D; Reierstad S; Lu M; Lin Z; Ishikawa H; Bulun SE
Cancer Lett; 2009 Jan; 273(1):15-27. PubMed ID: 18614276
[TBL] [Abstract][Full Text] [Related]
5. Aromatase gene expression in adipose tissue: relationship to breast cancer.
Simpson ER; Mahendroo MS; Nichols JE; Bulun SE
Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():75-83. PubMed ID: 7874190
[TBL] [Abstract][Full Text] [Related]
6. Regulation of aromatase expression in breast cancer tissue.
Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
[TBL] [Abstract][Full Text] [Related]
7. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
[TBL] [Abstract][Full Text] [Related]
8. Interference of endocrine disrupting chemicals with aromatase CYP19 expression or activity, and consequences for reproduction of teleost fish.
Cheshenko K; Pakdel F; Segner H; Kah O; Eggen RI
Gen Comp Endocrinol; 2008 Jan; 155(1):31-62. PubMed ID: 17459383
[TBL] [Abstract][Full Text] [Related]
9. Aromatase expression in health and disease.
Simpson ER; Zhao Y; Agarwal VR; Michael MD; Bulun SE; Hinshelwood MM; Graham-Lorence S; Sun T; Fisher CR; Qin K; Mendelson CR
Recent Prog Horm Res; 1997; 52():185-213; discussion 213-4. PubMed ID: 9238853
[TBL] [Abstract][Full Text] [Related]
10. Aromatase: biologic relevance of tissue-specific expression.
Simpson ER
Semin Reprod Med; 2004 Feb; 22(1):11-23. PubMed ID: 15083377
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells.
Ghosh S; Lu Y; Katz A; Hu Y; Li R
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E246-52. PubMed ID: 16940470
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic mechanisms regulating CYP19 transcription in human breast adipose fibroblasts.
Knower KC; To SQ; Simpson ER; Clyne CD
Mol Cell Endocrinol; 2010 Jun; 321(2):123-30. PubMed ID: 20211687
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
Prosperi JR; Robertson FM
Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
[TBL] [Abstract][Full Text] [Related]
14. The essential role of the aromatase/p450arom.
Meinhardt U; Mullis PE
Semin Reprod Med; 2002 Aug; 20(3):277-84. PubMed ID: 12428207
[TBL] [Abstract][Full Text] [Related]
15. [Exon 5 alternative splicing of the cytochrome P450 aromatase could be a regulatory mechanism for estrogen production in humans].
Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Berensztein E; Rivarola MA; Belgorosky A
Medicina (B Aires); 2007; 67(4):369-73. PubMed ID: 17891933
[TBL] [Abstract][Full Text] [Related]
16. Aromatase in the context of breast and endometrial cancer. A review.
Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ
Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363
[TBL] [Abstract][Full Text] [Related]
17. Regulation of aromatase expression by the nuclear receptor LRH-1 in adipose tissue.
Clyne CD; Kovacic A; Speed CJ; Zhou J; Pezzi V; Simpson ER
Mol Cell Endocrinol; 2004 Feb; 215(1-2):39-44. PubMed ID: 15026173
[TBL] [Abstract][Full Text] [Related]
18. Different promoter usage for CYP19 gene expression in buffalo ovary and placenta.
Sharma D; Ghai S; Singh D
Gen Comp Endocrinol; 2009 Jul; 162(3):319-28. PubMed ID: 19375426
[TBL] [Abstract][Full Text] [Related]
19. Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women.
Agarwal VR; Ashanullah CI; Simpson ER; Bulun SE
J Clin Endocrinol Metab; 1997 Jan; 82(1):70-4. PubMed ID: 8989235
[TBL] [Abstract][Full Text] [Related]
20. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
